[4] [4] LEUNG A Y L, ZHANG J L, CHAN C Y, et al. Validation of evidence-based questionnaire for TCM syndrome differentiation of heart failure and evaluation of expert consensus[J]. Chin Med, 2023, 18(1): 70. DOI: 10.1186/s13020-023-00757-1.

[30] [30] YANG J, TIAN S S, ZHAO J, et al. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning[J]. Pharmacol Res, 2020, 159: 105034. DOI: 10.1016/j.phrs.2020.105034.

[31] [31] GUO R, LUO X L, LIU J J, et al. Omics strategies decipher therapeutic discoveries of traditional Chinese medicine against different diseases at multiple layers molecular-level[J]. Pharmacol Res, 2020, 152: 104627. DOI: 10.1016/j.phrs.2020.104627.

[35] [35] JIANG Y, ZHAO Q, HUANG S M, et al. Identification and comparison of potential biomarkers by proteomic analysis in traditional Chinese medicine-based heart failure syndromes[J]. Evid Based Complement Alternat Med, 2022, 2022: 6338508. DOI: 10.1155/2022/6338508.

[38] [38] CHAI C Z, KOU J P, ZHU D N, et al. Mice exposed to chronic intermittent hypoxia simulate clinical features of deficiency of both qi and Yin syndrome in traditional Chinese medicine[J]. Evid Based Complement Alternat Med, 2011, 2011: 356252. DOI: 10.1093/ecam/nep226.